• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Arthritis News / A Reappraisal of HAQ Disability in Rheumatoid Arthritis (RA)

A Reappraisal of HAQ Disability in Rheumatoid Arthritis (RA)

April 13, 2005 By Arthritis Center

(Wolfe, Arthritis Rheum 43:2751-2761) A fundamental paradigm of RA is that disease activity acting over time produces functional disability. Patient self-report assessment (rather than physician assessment) of disability is the standard in RA and is routinely used in clinical trials. The Health Assessment Questionnaire (HAQ) is the most common assessment tool for functional disability, and is a 20-item questionnaire in which scores range from 0 to 3 and increase in steps of 0.125. Wolfe reexamined the hypothesis that HAQ disability is a good model of disability, using data from a large, prospective, long-term study of disability in RA.

Methods:

The course of HAQ disability was assessed in 32,525 observations (1,843 patients) in which the HAQ was administered. In addition, the course of HAQ disability in individual patients was studied in a subset of 2,189 visits from 50 patients followed for an average of 17 years, in order to model the effect of disease duration on the course of HAQ disability.

Results:

Group linear and nonlinear models of the effect of disease duration on HAQ disability shared 3 characteristics: 1) HAQ disability scores are high at disease onset rather than gradually increasing; 2) HAQ disability increases very slowly over time (0.03 units per year); and 3) all such models fit very poorly, explaining only 5% of the variance in HAQ disability scores. In contrast, application of nonlinear models to individual patient courses (as opposed to groups of patients) explains 37% of the HAQ disability score variation. In some patients, the course of HAQ disability was either: 1) chaotic (scores change without any pattern); 2) determinable, but unrelated to time. When covariates were added to the group model, 51% of the variance in the disability score could be explained statistically by pain, depression, erythrocyte sedimentation rate, and disease duration.

Conclusions:

Individual RA patients have differing, characterizable courses: 1) nonlinear, 2) chaotic, or 3) non-time determined. The model that self-reported physical disability occurs as a function of disease acting over time did not fit the data well and was an inadequate model. Individual patient models may be a more effective way to examine the course of RA than are conventional group-based models.

Editorial Comment:

This is an important study that calls into serious question the long-held notion that duration of disease is linearly related to disability. As the author points out, current disease activity, pain and psychological factors probably play a much more important role in determining self-reported disability than years of disease or structural damage to the joints. This information should be considered in the design and analysis of data from clinical trials which assume a linear increase in disability over time in RA.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Use of this Site

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Recent News

Exercise Tips for Arthritis Patients

How Does Exercise Affect my Joints? How Frequently Should I Be Exercising? Should I Lose Weight for Exercise to be

Risks and Benefits of Biologic Medications

Victoria Ruffing, RN, BC, Director of Patient Education at the Johns Hopkins Arthritis Center, shares the risks and benefits of biologic for

How to Manage Rheumatoid Arthritis Flares

Through research, doctors have a clearer understanding of how flares can impact a patient on a personal and emotional level. Dr. Uzma Haque

Complementary & Alternative Medicines for Psoriatic Arthritis

There are many complementary & alternative medicines and practices that have been found to be beneficial in curbing arthritis pain,

I can’t be a runner because I have Rheumatoid Arthritis (RA), right?

Dr. Manno discusses running and Rheumatoid Arthritis. Is it an option for the RA patient?

News Categories

  • Ankylosing Spondylitis News
  • Fibromyalgia News
  • Gout News
  • Lupus News
  • Osteoarthritis News
  • Osteoporosis News
  • Psoriatic Arthritis News
  • Rheumatoid Arthritis News
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy